Julio Chavez
465 posts
@JulioChavezMD
Lymphoma. Immunotherapy. Tweets are my own views
In a challenge to open-access publishers, the Chinese Academy of Sciences, the world’s largest research institution, has told its researchers it plans to stop paying to publish their papers in dozens of international free-to-read journals it regards as too expensive. scim.ag/4tU6qD5
@LocasaleLab It is insane to me that senior authors don't have the lion share of the accountability. Whether it is corrupt or not, it decreases confidence in a time when confidence is already exteemely low.
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma. Read the full article. brnw.ch/21wY5iS
While the American Medical Association is lecturing the world about equity and diversity, their administrators are taking home Wall Street–level compensation packages — paid for by academic medical centers and the NIH. This is the medical-school industrial complex: a bureaucracy burning through public money, eroding science, and hiding behind moral grandstanding.
MajesTEC-3 ASH LBA Best result ever in a RRMM randomized trial. It will transform how we approach myeloma. Congratulations to authors and @JNJNews meetings-api.hematology.org/api/abstract/v…
